LifeVest Wearable Defibrillator
Zoll Manufacturing Corporation · Decision date Sep 9, 2026
What did the FDA approve?
The FDA recorded an approval dated 2026-09-09 for P010030/S201, a real-time process supplement submitted by Zoll Manufacturing Corporation under the reason Change Design/Components/Specifications/Material. The listed statement describes approval for an additional battery pack variant for the LifeVest 5100, to be manufactured by a new Tier 1 supplier. The product code is MVK, in the Cardiovascular specialty.
Because the identifier is a supplement to P010030, this action modifies the existing approval rather than approving the LifeVest system anew. The statement does not identify the supplier, the battery pack's specifications or materials, the specific components changed, or any testing, performance data, or clinical evidence. The record also gives no safety or effectiveness finding, so the approval purpose should not be read as independent proof of either.
FDA approval order statement
approval for an additional battery pack variant for the LifeVest 5100 to be manufactured by a new Tier 1 supplier
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 9, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P010030/S201
- Regulatory pathway
- PMA supplement
- Applicant
- Zoll Manufacturing Corporation
- Product code
- MVK
- Decision code
- APPR
- Decision date
- Sep 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wearable automated external defibrillator.
- Applicant
- Zoll Manufacturing Corporation
- Product code
- MVK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P010030. Subsequent supplements may change the device or its indications.
FDA decision timeline
P010030 · Original PMA
WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) 2000 LIFEVEST
P010030/S201 received
Application receipt date recorded by FDA.
P010030/S201 · FDA decision
Real-Time Process
P010030/S203 · Related supplement
LifeVest Wearable Defibrillator
P010030/S204 · Related supplement
LifeVest Wearable Defibrillator
P010030/S205 · Related supplement
LifeVest Wearable Defibrillator
Timeline entries are records held by MedtechLedger for P010030. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P010030
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zoll Manufacturing Corporation | PMA approval | Dec 18, 2001 | FDA | |
LifeVest Wearable DefibrillatorP010030/S203 | Zoll Manufacturing Corporation | PMA supplement | Sep 29, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S204 | Zoll Manufacturing Corporation | PMA supplement | Oct 5, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S205 | Zoll Manufacturing Corporation | PMA supplement | Oct 6, 2026 | FDA |
Explore the linked device profile
Other records with product code MVK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Kestra Medical Technologies, Inc. | PMA supplement | Nov 4, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Sep 28, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA approval | Jul 27, 2021 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zoll Manufacturing Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 121 Gamma Dr., Pittsburgh, PA, 15238
Sources and methodology
- Original FDA record: P010030/S201
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




